Pfizer and BioNTech Secure U.S. Patent Victory While Facing Setback in German Court Against Moderna
In a pivotal patent dispute over COVID-19 vaccine technology, Pfizer and BioNTech achieve a significant ruling in the United States but encounter a loss in Germany, underscoring t…
Pfizer and BioNTech have recently experienced contrasting outcomes in their ongoing patent litigation with Moderna concerning mRNA COVID-19 vaccines. The U.S. courts ruled in favor of Pfizer and BioNTech, granting them a crucial patent-related win. Conversely, German courts ruled against the duo, marking a notable def…
